You have 9 free searches left this month | to do more

pirtobrutinib

Pirtobrutinib is a drug used to treat Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-cell Lymphoma, and other conditions. Pirtobrutinib is being actively studied in 3 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Loxo Oncology, Inc.Memorial Sloan Kettering Cancer Center
Eli Lilly and CompanyNagoya Medical Center
CHRU De Tours
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
L
A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Pirtobrutinib
  • +2 more
  • Los Angeles, California
  • +2 more
2021-11-10
Nov 10, 2021
L
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Pirtobrutinib
  • +2 more
  • Fort Myers, Florida
  • +26 more
2021-11-16
Nov 16, 2021
E
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
Recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Miami, Florida
  • +2 more
2021-11-19
Nov 19, 2021